BCS waiver [Dissolution / BCS / IVIVC]

posted by Mauricio Sampaio  – Brazil, 2016-05-18 17:58 (3336 d 10:21 ago) – Posting: # 16326
Views: 5,701

Hi!
Bad news for you!
According Capecitabine Product-Specific Bioequivalence Guidance from EMA, Capecitabine is an unstable compound in acidic medium. Absorption is almost complete. The available data on solubility does not allow its BCS classification. Then, I think that a possibility for biowaiver of capecitabine is impossible according current rules.

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,679 registered users;
36 visitors (0 registered, 36 guests [including 16 identified bots]).
Forum time: 04:20 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5